Table of Content

1 Haemophilus Influenzae Type B Injection Vaccine Market Overview
1.1 Product Overview and Scope of Haemophilus Influenzae Type B Injection Vaccine
1.2 Haemophilus Influenzae Type B Injection Vaccine Segment by Type
1.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Lyophilized
1.2.3 Non-lyophilized
1.3 Haemophilus Influenzae Type B Injection Vaccine Segment by Application
1.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Haemophilus Influenzae Type B Injection Vaccine Market Size Estimates and Forecasts
1.4.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue 2024-2034
1.4.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales 2024-2034
1.4.3 Global Haemophilus Influenzae Type B Injection Vaccine Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Haemophilus Influenzae Type B Injection Vaccine Market Competition by Manufacturers
2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Manufacturers (2024-2024)
2.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Haemophilus Influenzae Type B Injection Vaccine Average Price by Manufacturers (2024-2024)
2.4 Global Haemophilus Influenzae Type B Injection Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Product Type & Application
2.7 Haemophilus Influenzae Type B Injection Vaccine Market Competitive Situation and Trends
2.7.1 Haemophilus Influenzae Type B Injection Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Haemophilus Influenzae Type B Injection Vaccine Players Market Share by Revenue
2.7.3 Global Haemophilus Influenzae Type B Injection Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Haemophilus Influenzae Type B Injection Vaccine Retrospective Market Scenario by Region
3.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Haemophilus Influenzae Type B Injection Vaccine Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2024-2034
3.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2024-2024
3.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2024-2034
3.3 Global Haemophilus Influenzae Type B Injection Vaccine Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2024-2034
3.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2024-2024
3.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2024-2034
3.4 North America Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
3.4.1 North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034)
3.4.3 North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
3.5.1 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034)
3.5.3 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034)
3.6.3 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
3.7.1 Latin America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034)
3.7.3 Latin America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034)
3.8.3 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2024-2034)
4.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2024-2024)
4.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2024-2034)
4.1.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2024-2034)
4.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2024-2024)
4.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2024-2034)
4.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Haemophilus Influenzae Type B Injection Vaccine Price by Type (2024-2034)
5 Segment by Application
5.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2024-2034)
5.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2024-2024)
5.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2024-2034)
5.1.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2024-2034)
5.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2024-2024)
5.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2024-2034)
5.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Haemophilus Influenzae Type B Injection Vaccine Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Corporation Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 Biokangtai
6.3.1 Biokangtai Corporation Information
6.3.2 Biokangtai Description and Business Overview
6.3.3 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.3.5 Biokangtai Recent Developments/Updates
6.4 Olymvax
6.4.1 Olymvax Corporation Information
6.4.2 Olymvax Description and Business Overview
6.4.3 Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.4.5 Olymvax Recent Developments/Updates
6.5 Sanofi Pasteur
6.5.1 Sanofi Pasteur Corporation Information
6.5.2 Sanofi Pasteur Description and Business Overview
6.5.3 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.5.5 Sanofi Pasteur Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Corporation Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Beijing Minhai Biotechnology Co., Ltd
6.6.1 Beijing Minhai Biotechnology Co., Ltd Corporation Information
6.6.2 Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
6.6.3 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.7.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates
6.8 Chengdu Institute of Biological Products Co., Ltd
6.8.1 Chengdu Institute of Biological Products Co., Ltd Corporation Information
6.8.2 Chengdu Institute of Biological Products Co., Ltd Description and Business Overview
6.8.3 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.8.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments/Updates
6.9 Yuxi Watson Biotechnology Co., Ltd
6.9.1 Yuxi Watson Biotechnology Co., Ltd Corporation Information
6.9.2 Yuxi Watson Biotechnology Co., Ltd Description and Business Overview
6.9.3 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.9.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
6.10 Lanzhou Institute of Biological Products Co., Ltd
6.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
6.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
6.10.3 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
6.11 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
6.11.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Corporation Information
6.11.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Description and Business Overview
6.11.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.11.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
6.12 Chengdu Oulin Biotechnology Co., Ltd
6.12.1 Chengdu Oulin Biotechnology Co., Ltd Corporation Information
6.12.2 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Description and Business Overview
6.12.3 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
6.12.5 Chengdu Oulin Biotechnology Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Haemophilus Influenzae Type B Injection Vaccine Industry Chain Analysis
7.2 Haemophilus Influenzae Type B Injection Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process
7.4 Haemophilus Influenzae Type B Injection Vaccine Sales and Marketing
7.4.1 Haemophilus Influenzae Type B Injection Vaccine Sales Channels
7.4.2 Haemophilus Influenzae Type B Injection Vaccine Distributors
7.5 Haemophilus Influenzae Type B Injection Vaccine Customers
8 Haemophilus Influenzae Type B Injection Vaccine Market Dynamics
8.1 Haemophilus Influenzae Type B Injection Vaccine Industry Trends
8.2 Haemophilus Influenzae Type B Injection Vaccine Market Drivers
8.3 Haemophilus Influenzae Type B Injection Vaccine Market Challenges
8.4 Haemophilus Influenzae Type B Injection Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Haemophilus Influenzae Type B Injection Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Haemophilus Influenzae Type B Injection Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Haemophilus Influenzae Type B Injection Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Haemophilus Influenzae Type B Injection Vaccine Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Haemophilus Influenzae Type B Injection Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Haemophilus Influenzae Type B Injection Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Haemophilus Influenzae Type B Injection Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Injection Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2024-2024) & (K Units)
Table 18. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2024-2024)
Table 19. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2024-2024)
Table 23. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2024) & (K Units)
Table 27. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2024) & (K Units)
Table 32. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units) by Type (2024-2024)
Table 51. Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2024-2024)
Table 53. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2024-2024)
Table 57. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Haemophilus Influenzae Type B Injection Vaccine Price (US$/Unit) by Type (2024-2024)
Table 59. Global Haemophilus Influenzae Type B Injection Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units) by Application (2024-2024)
Table 61. Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2024-2024)
Table 63. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Haemophilus Influenzae Type B Injection Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2024-2024)
Table 67. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Haemophilus Influenzae Type B Injection Vaccine Price (US$/Unit) by Application (2024-2024)
Table 69. Global Haemophilus Influenzae Type B Injection Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. Bharat Biotech Corporation Information
Table 71. Bharat Biotech Description and Business Overview
Table 72. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product
Table 74. Bharat Biotech Recent Developments/Updates
Table 75. Glaxosmithkline Corporation Information
Table 76. Glaxosmithkline Description and Business Overview
Table 77. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product
Table 79. Glaxosmithkline Recent Developments/Updates
Table 80. Biokangtai Corporation Information
Table 81. Biokangtai Description and Business Overview
Table 82. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product
Table 84. Biokangtai Recent Developments/Updates
Table 85. Olymvax Corporation Information
Table 86. Olymvax Description and Business Overview
Table 87. Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Olymvax Haemophilus Influenzae Type B Injection Vaccine Product
Table 89. Olymvax Recent Developments/Updates
Table 90. Sanofi Pasteur Corporation Information
Table 91. Sanofi Pasteur Description and Business Overview
Table 92. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product
Table 94. Sanofi Pasteur Recent Developments/Updates
Table 95. Walvax Biotechnology Corporation Information
Table 96. Walvax Biotechnology Description and Business Overview
Table 97. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product
Table 99. Walvax Biotechnology Recent Developments/Updates
Table 100. Beijing Minhai Biotechnology Co., Ltd Corporation Information
Table 101. Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
Table 102. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product
Table 104. Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates
Table 105. Chengdu Institute of Biological Products Co., Ltd Corporation Information
Table 106. Chengdu Institute of Biological Products Co., Ltd Description and Business Overview
Table 107. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product
Table 109. Chengdu Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 110. Yuxi Watson Biotechnology Co., Ltd Corporation Information
Table 111. Yuxi Watson Biotechnology Co., Ltd Description and Business Overview
Table 112. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product
Table 114. Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
Table 115. Lanzhou Institute of Biological Products Co., Ltd Corporation Information
Table 116. Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
Table 117. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product
Table 119. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 120. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Corporation Information
Table 121. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Description and Business Overview
Table 122. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product
Table 124. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 125. Chengdu Oulin Biotechnology Co., Ltd Corporation Information
Table 126. Chengdu Oulin Biotechnology Co., Ltd Description and Business Overview
Table 127. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product
Table 129. Chengdu Oulin Biotechnology Co., Ltd Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Haemophilus Influenzae Type B Injection Vaccine Distributors List
Table 133. Haemophilus Influenzae Type B Injection Vaccine Customers List
Table 134. Haemophilus Influenzae Type B Injection Vaccine Market Trends
Table 135. Haemophilus Influenzae Type B Injection Vaccine Market Drivers
Table 136. Haemophilus Influenzae Type B Injection Vaccine Market Challenges
Table 137. Haemophilus Influenzae Type B Injection Vaccine Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Haemophilus Influenzae Type B Injection Vaccine
Figure 2. Global Haemophilus Influenzae Type B Injection Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Haemophilus Influenzae Type B Injection Vaccine Market Share by Type in 2022 & 2034
Figure 4. Lyophilized Product Picture
Figure 5. Non-lyophilized Product Picture
Figure 6. Global Haemophilus Influenzae Type B Injection Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Haemophilus Influenzae Type B Injection Vaccine Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Haemophilus Influenzae Type B Injection Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 11. Global Haemophilus Influenzae Type B Injection Vaccine Market Size (2024-2034) & (US$ Million)
Figure 12. Global Haemophilus Influenzae Type B Injection Vaccine Sales (2024-2034) & (K Units)
Figure 13. Global Haemophilus Influenzae Type B Injection Vaccine Average Price (US$/Unit) & (2024-2034)
Figure 14. Haemophilus Influenzae Type B Injection Vaccine Report Years Considered
Figure 15. Haemophilus Influenzae Type B Injection Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Haemophilus Influenzae Type B Injection Vaccine Players: Market Share by Revenue in 2022
Figure 18. Haemophilus Influenzae Type B Injection Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 19. Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 20. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2024-2034)
Figure 21. North America Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2024-2034)
Figure 22. United States Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 23. Canada Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2024-2034)
Figure 25. Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2024-2034)
Figure 26. Germany Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. France Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. U.K. Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Italy Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Russia Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2024-2034)
Figure 32. Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2024-2034)
Figure 33. China Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Japan Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. South Korea Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. India Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Australia Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. China Taiwan Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2024-2034)
Figure 41. Latin America Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2024-2034)
Figure 42. Mexico Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Brazil Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Argentina Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2024-2034)
Figure 46. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Country (2024-2034)
Figure 47. Turkey Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. UAE Haemophilus Influenzae Type B Injection Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Global Sales Market Share of Haemophilus Influenzae Type B Injection Vaccine by Type (2024-2034)
Figure 51. Global Revenue Market Share of Haemophilus Influenzae Type B Injection Vaccine by Type (2024-2034)
Figure 52. Global Haemophilus Influenzae Type B Injection Vaccine Price (US$/Unit) by Type (2024-2034)
Figure 53. Global Sales Market Share of Haemophilus Influenzae Type B Injection Vaccine by Application (2024-2034)
Figure 54. Global Revenue Market Share of Haemophilus Influenzae Type B Injection Vaccine by Application (2024-2034)
Figure 55. Global Haemophilus Influenzae Type B Injection Vaccine Price (US$/Unit) by Application (2024-2034)
Figure 56. Haemophilus Influenzae Type B Injection Vaccine Value Chain
Figure 57. Haemophilus Influenzae Type B Injection Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed